Veterinary orthopedic medicine market to reach $5.99 billion by 2030

By AI, Created 10:48 AM UTC, May 20, 2026, /AGP/ – The veterinary orthopedic medicine market is projected to grow from $4.03 billion in 2025 to $5.99 billion by 2030, driven by rising orthopedic disease in pets, more advanced treatments and broader access to specialty care. North America was the largest regional market in 2025, while the report points to continued growth across Asia-Pacific, Europe and other regions.

Why it matters: - Veterinary orthopedic medicine is growing as more pet owners seek specialized care for fractures, arthritis and other musculoskeletal problems. - The market’s expansion reflects rising demand for treatments that can reduce pain, improve mobility and extend quality of life for companion animals. - Pet orthopedic disease is becoming harder to ignore as animals live longer and obesity and inactivity remain common.

What happened: - The Business Research Company projected the veterinary orthopedic medicine market will rise from $4.03 billion in 2025 to $4.4 billion in 2026. - The report forecasts the market will reach $5.99 billion by 2030. - The company said the market was supported by stronger demand for specialized animal care and new treatment options. - North America was the largest veterinary orthopedic medicine market in 2025.

The details: - The report links near-term growth to a 9.1% compound annual growth rate in 2026. - The longer-term forecast implies an 8.0% compound annual growth rate through 2030. - Historical growth has been tied to high rates of osteoarthritis and joint disorders, more companion animals, earlier limits on advanced orthopedic treatment, growth in equine and canine sports, and the expansion of veterinary hospitals and clinics. - Future growth is expected to come from platelet-rich plasma, or PRP, therapy, stem cell therapy, viscosupplements, nonsteroidal anti-inflammatory drugs and newer surgical techniques. - The report also points to rising investment in veterinary orthopedic research and a greater focus on animal mobility and life quality. - The market trends highlighted include more musculoskeletal disorders, broader use of minimally invasive surgery, expansion of biologics and stem cell treatments, more rehabilitation and physiotherapy services, and stronger emphasis on pain management and post-operative recovery. - Veterinary orthopedic medicine covers diagnosis, management and prevention of musculoskeletal problems in animals. - The field includes treatment for fractures, arthritis, congenital deformities and soft tissue injuries. - Treatments include surgery, physical therapy and rehabilitation. - A July 2024 Morris Animal Foundation report found more than 14 million adult dogs in the United States have osteoarthritis. - The same data showed about 90% of cats older than 12 have radiographic evidence of osteoarthritis. - The report reviewed North America, Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The company offered a free sample of the report and a full market report.

Between the lines: - The forecast suggests veterinary orthopedics is moving from a niche specialty toward a more routine part of pet healthcare. - Rising osteoarthritis rates in aging dogs and cats are likely to keep pressure on clinics and specialty providers. - The focus on biologics, stem cells and minimally invasive procedures points to a market shifting toward higher-value, less invasive care.

What’s next: - The report expects continued growth through 2030 as treatment adoption widens and more clinics add advanced orthopedic services. - Demand is likely to increase for rehabilitation, physiotherapy and pain management as post-operative care becomes more central to treatment. - The largest regional opportunities may remain in North America, with additional growth potential across Asia-Pacific and other covered markets.

The bottom line: - Veterinary orthopedic medicine is on track for steady growth through the end of the decade, fueled by rising pet arthritis rates and broader adoption of advanced care.